Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Drake-Scruggs Equipment Inc is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Zetta Medical Technologies is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lake Zurich, IL. To find more information about Zetta Medical Technologies, please visit www.zettamed.com
THE WELL is a modern membership-based wellness club designed for busy urban professionals in the heart of New York City.
Southern Plaza Retirement Comm is a Bethany, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.